A detailed history of Fox Run Management, L.L.C. transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 41,988 shares of WVE stock, worth $290,137. This represents 0.05% of its overall portfolio holdings.

Number of Shares
41,988
Holding current value
$290,137
% of portfolio
0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$6.66 - $10.15 $279,640 - $426,178
41,988 New
41,988 $302,000
Q4 2023

Feb 13, 2024

BUY
$4.16 - $6.87 $83,420 - $137,764
20,053 New
20,053 $101,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $600M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Fox Run Management, L.L.C. Portfolio

Follow Fox Run Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fox Run Management, L.L.C. with notifications on news.